Concepedia

Alexis de Haven Brandon

AD

31

Publications

2.9K

Citations

25

H-Index

2007

Active since

Affiliations

Institute of Cancer Research(Current)

Cancer Research UK

Royal Marsden Hospital

Royal Marsden NHS Foundation Trust

Breast Cancer Now

Alexis de Haven Brandon is an author at Institute of Cancer Research specializing in medicine, natural sciences, and drug discovery.

Top concepts

Publications per year

2007–2020

31

Publications

31

NVP-AUY922: A Novel Heat Shock Protein 90 Inhibitor Active against Xenograft Tumor Growth, Angiogenesis, and Metastasis

Suzanne A. Eccles, Andy Massey, Florence I. Raynaud et al. · Cancer Research · 2008 · 469 citations

Pharmacologic Characterization of a Potent Inhibitor of Class I Phosphatidylinositide 3-Kinases

Florence I. Raynaud, Suzanne A. Eccles, Paul A. Clarke et al. · Cancer Research · 2007 · 349 citations · Full text

Biological properties of potent inhibitors of class I phosphatidylinositide 3-kinases: from PI-103 through PI-540, PI-620 to the oral agent GDC-0941

Florence I. Raynaud, Suzanne A. Eccles, Sonal Patel et al. · Molecular Cancer Therapeutics · 2009 · 270 citations · Full text

Dual Blockade of the PI3K/AKT/mTOR (AZD8055) and RAS/MEK/ERK (AZD6244) Pathways Synergistically Inhibits Rhabdomyosarcoma Cell Growth <i>In Vitro</i> and <i>In Vivo</i>

Jane Renshaw, Kathryn R. Taylor, Ryan T. Bishop et al. · Clinical Cancer Research · 2013 · 149 citations · Full text

A selective chemical probe for exploring the role of CDK8 and CDK19 in human disease

Trevor Dale, Paul A. Clarke, Christina Esdar et al. · Nature Chemical Biology · 2015 · 139 citations · Full text

, , +7

Rows per page

1–5 of 31